- Home
- FND vs ROIV Comparison
FND vs ROIV Comparison
Compare FND & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FND
- ROIV
- Stock Information
- Founded
- FND 2000
- ROIV 2014
- Country
- FND United States
- ROIV United Kingdom
- Employees
- FND N/A
- ROIV N/A
- Industry
- FND RETAIL: Building Materials
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- FND Consumer Discretionary
- ROIV Health Care
- Exchange
- FND Nasdaq
- ROIV Nasdaq
- Market Cap
- FND 7.9B
- ROIV 8.4B
- IPO Year
- FND 2017
- ROIV N/A
- Fundamental
- Price
- FND $79.54
- ROIV $10.79
- Analyst Decision
- FND Hold
- ROIV Buy
- Analyst Count
- FND 19
- ROIV 4
- Target Price
- FND $94.68
- ROIV $17.50
- AVG Volume (30 Days)
- FND 2.6M
- ROIV 5.9M
- Earning Date
- FND 05-01-2025
- ROIV 05-29-2025
- Dividend Yield
- FND N/A
- ROIV N/A
- EPS Growth
- FND N/A
- ROIV N/A
- EPS
- FND 1.89
- ROIV N/A
- Revenue
- FND $4,519,221,000.00
- ROIV $122,585,000.00
- Revenue This Year
- FND $7.59
- ROIV N/A
- Revenue Next Year
- FND $10.93
- ROIV N/A
- P/E Ratio
- FND $42.02
- ROIV N/A
- Revenue Growth
- FND 2.96
- ROIV 140.04
- 52 Week Low
- FND $66.01
- ROIV $8.73
- 52 Week High
- FND $126.74
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- FND 56.15
- ROIV 50.06
- Support Level
- FND $72.78
- ROIV $10.58
- Resistance Level
- FND $86.23
- ROIV $11.77
- Average True Range (ATR)
- FND 2.62
- ROIV 0.34
- MACD
- FND 1.18
- ROIV -0.07
- Stochastic Oscillator
- FND 57.69
- ROIV 17.65
About FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.